Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting
Clinical trial NCT05266495 · TERMINATED
Trial details
- NCT number
- NCT05266495
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-13
- Primary completion
- 2023-03-13
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.